Skip to main content
Retour
Watch Compare

Nu-Med Plus, Inc.

Qualité des données : 83%
NUMD
OTC Manufacturing Measuring & Analyzing Instruments
0,01 €
▲ 0,00 € (9,24%)
Cap. Boursière: 1,09 M
Prix
0,01 €
Cap. Boursière
1,09 M
Fourchette du Jour
0,01 € — 0,01 €
Fourchette 52 Semaines
0,01 € — 0,10 €
Volume
14 200
Ouverture 0,01 €
Moyenne 50J / 200J
0,01 €
6,47% below
Moyenne 50J / 200J
0,03 €
52,73% below

Quick Summary

Points Clés

Negative free cash flow of -4 433,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,03
Interest Coverage-12,63

Valorisation

PE (TTM)
-15,89
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -15,9 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -68 345,0
ROE N/A ROA -862,02%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4 433,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,03
Interest Coverage -12,63 Asset Turnover N/A
Working Capital -204 541 Tangible Book Value -204 541
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -15,89 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,41%
Market Cap 1,09 M Enterprise Value 1,09 M
Per Share
EPS (Diluted TTM) 0,00 Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 6,49%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — 0,0
Net Income -68 345,0 -125 526,0 -130 167,0 -830 061,0 -2,01 M
EPS (Diluted) 0,00 0,00 0,00 -0,01 -0,04
Gross Profit — — — — —
Operating Income -63 331,0 -120 526,0 -182 167,0 -839 445,0 -1,99 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — 2 267,0 2 267,0 9 365,0 11 794,0
Interest Expense 5 014,0 -5 000,0 1 000,0 14 322,0 14 322,0
Income Tax — — — — 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 9 373,0 13 456,0 79 545,0 22 163,0 557 135,0
Total Liabilities 224 469,0 160 207,0 142 570,0 154 521,0 89 432,0
Shareholders' Equity -215 096,0 -146 751,0 -63 025,0 -132 358,0 467 703,0
Total Debt — — — — —
Cash & Equivalents 2 373,0 — — 188 506,0 188 506,0
Current Assets 9 373,0 13 456,0 79 545,0 11 675,0 537 523,0
Current Liabilities 224 469,0 160 207,0 142 570,0 154 521,0 80 048,0